ClinicalTrials.gov record
Completed Phase 1 Interventional

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

ClinicalTrials.gov ID: NCT00891137

Public ClinicalTrials.gov record NCT00891137. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 3:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I Trial to Determine Safety and Tolerability of Ex Vivo Expanded Human Myeloid Progenitor Cells (CLT-008) Infused 24 Hours Post-Transplant to Support Allogeneic Umbilical Cord Blood Transplantation for Hematologic Malignancies

Study identification

NCT ID
NCT00891137
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Cellerant Therapeutics
Industry
Enrollment
30 participants

Conditions and interventions

Interventions

  • human myeloid progenitor cells Biological

Biological

Eligibility (public fields only)

Age range
12 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2009
Primary completion
May 31, 2014
Completion
May 31, 2014
Last update posted
Oct 26, 2014

2009 – 2014

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Children's Hospital of Orange County Orange California 92868
Alfred I. duPont Hospital for Children Wilmington Delaware 19803
Children's National Medical Center Washington D.C. District of Columbia 20010
Loyola University Medical Center, Cardinal Bernardin Cancer Center Maywood Illinois 60153
University of Minnesota: Masonic Cancer Center, BMT Clinic, and Fairview Medical Center Minneapolis Minnesota 55455
Cleveland Clinic, Taussig Cancer Institute Cleveland Ohio 44195
Nationwide Children's Hospital Columbus Ohio 43205
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00891137, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 26, 2014 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00891137 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →